appengine.ai

Artificial Intelligence | Machine Learning | Natural Language Processing Ablacon | AI-guided Atrial Fibrillation Therapies.


Consumer, Heart, Therapeutics, Healthcare, Medical Records, Analytics, Patient Support Greater Denver Area, Western US, CO, Western US

Ablacon

Artificial Intelligence | Machine Learning | Natural Language Processing


Ablacon | AI-guided Atrial Fibrillation Therapies.

Ablacon

Heart, Therapeutics, Healthcare, Medical Records, Analytics, Patient Support


Greater Denver Area, Western US, CO, Western US

Atrial Fibrillation (AF) is the most frequent arrhythmic disorder of the heart. At Ablacon, we leverage our expertise in electrophysiology, computer vision and deep learning to build a real-time high-precision AI-based diagnosis system.

We are an international team based in Lausanne (CH), Denver, CO (US) and Munich (DE) with a partner clinic in Hamburg (DE).

 

B2G, B2B

26 to 50

Series B

$33.5M

Development

2015

 
 

Managed Health Care
Healthcare
Health Care Facilities & Hospitals

N/A

Healthcare

 
 

Analytics
IT and Security

Yes

Active

 
 

   Machine Learning
   Natural Language Processing


Electrographic Flow Mapping

Electrographic Flow Mapping


Image

Image

Video

Video

Text

Text

Time Series

Time Series

 

   Software


NA

NA


NA

NA

 
 
Duke Rohlen


Duke Rohlen
CEO

Josef Koblish

Josef Koblish
Chief Strategy Officer

Peter Ruppersberg


Peter Ruppersberg
Chief Scientific Officer & President

Melissa Kong


Melissa Kong
Associate Medical Director